MX9100450A - Reduccion de niveles de acido urico en la sangre - Google Patents

Reduccion de niveles de acido urico en la sangre

Info

Publication number
MX9100450A
MX9100450A MX9100450A MX9100450A MX9100450A MX 9100450 A MX9100450 A MX 9100450A MX 9100450 A MX9100450 A MX 9100450A MX 9100450 A MX9100450 A MX 9100450A MX 9100450 A MX9100450 A MX 9100450A
Authority
MX
Mexico
Prior art keywords
uric acid
acid levels
blood
reduction
hydroxy
Prior art date
Application number
MX9100450A
Other languages
English (en)
Inventor
Paden C Going
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX9100450A publication Critical patent/MX9100450A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX9100450A 1990-08-02 1991-07-31 Reduccion de niveles de acido urico en la sangre MX9100450A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/562,096 US5064830A (en) 1990-08-02 1990-08-02 Lowering of blood uric acid levels

Publications (1)

Publication Number Publication Date
MX9100450A true MX9100450A (es) 1992-04-01

Family

ID=24244779

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9100450A MX9100450A (es) 1990-08-02 1991-07-31 Reduccion de niveles de acido urico en la sangre

Country Status (16)

Country Link
US (1) US5064830A (es)
EP (1) EP0469837B1 (es)
JP (1) JPH04234321A (es)
KR (1) KR940002665B1 (es)
AT (1) ATE113840T1 (es)
AU (1) AU622590B2 (es)
CA (1) CA2048235C (es)
DE (1) DE69105069T2 (es)
DK (1) DK0469837T3 (es)
HU (1) HUT61665A (es)
IE (1) IE64046B1 (es)
IL (1) IL98979A (es)
MX (1) MX9100450A (es)
NZ (1) NZ239215A (es)
PT (1) PT98509B (es)
ZA (1) ZA916060B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5391551A (en) * 1993-05-10 1995-02-21 Pfizer Inc. Method of lowering blood lipid levels
US6127367A (en) * 1996-02-29 2000-10-03 Pfizer, Inc. Method of reducing tissue damage associated with non-cardiac ischemia
IL124236A (en) * 1997-05-05 2003-01-12 Pfizer Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor
WO2011046800A1 (en) * 2009-10-13 2011-04-21 Wellstat Therapeutics Corporation 3-substituted compounds for reducing uric acid
WO2017176777A1 (en) * 2016-04-04 2017-10-12 Aviragen Therapeutics, Inc. Bta-c585 for the treatment and/or prevention of conditions related to or associated with hyperuricemia or hyperuricosuria and other conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2032749T3 (es) * 1985-11-07 1993-03-01 Pfizer Inc. Acidos oxoftalazinil-aceticos heterociclicos.
US4939140A (en) * 1985-11-07 1990-07-03 Pfizer Inc. Heterocyclic oxophthalazinyl acetic acids
GB8704569D0 (en) * 1987-02-26 1987-04-01 Ici America Inc Therapeutic agent
JPH0676391B2 (ja) * 1987-06-09 1994-09-28 フアイザー・インコーポレイテツド ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法
EP0322153A3 (en) * 1987-12-21 1990-08-16 Pfizer Inc. Heterocyclic oxophtalazinyl acetic acids

Also Published As

Publication number Publication date
EP0469837A2 (en) 1992-02-05
CA2048235C (en) 1995-05-30
HU912567D0 (en) 1992-01-28
US5064830A (en) 1991-11-12
IE912721A1 (en) 1992-02-12
DE69105069D1 (de) 1994-12-15
ATE113840T1 (de) 1994-11-15
PT98509A (pt) 1992-06-30
PT98509B (pt) 1999-01-29
ZA916060B (en) 1993-03-31
DK0469837T3 (da) 1994-12-27
EP0469837B1 (en) 1994-11-09
EP0469837A3 (en) 1992-04-08
KR940002665B1 (ko) 1994-03-28
NZ239215A (en) 1997-07-27
IE64046B1 (en) 1995-06-28
KR920003970A (ko) 1992-03-27
AU8156091A (en) 1992-02-06
JPH04234321A (ja) 1992-08-24
AU622590B2 (en) 1992-04-09
HUT61665A (en) 1993-03-01
IL98979A0 (en) 1992-07-15
DE69105069T2 (de) 1995-03-09
IL98979A (en) 1996-11-14

Similar Documents

Publication Publication Date Title
FI941378A (fi) Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus
DE3773660D1 (de) Morpholinoethylester von mycophenolsaeure und ihre derivate, ihre herstellung und verwendung in pharmazeutische zusammensetzungen.
FI873631A (fi) --alkyl-4-amino-3-kinolinmetanoler och 1-(4-aralkylamino-3-kinolinyl)alkanoler, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
NO934792L (no) Xantinderivater
FI904659A0 (fi) Nya benzimidazolfoereningar och deras anvaendning.
DK0916651T3 (da) Phenylalkylcarboxylsyrederivater
DE3882895T2 (de) Imid-Derivate, ihre Herstellung und Verwendung.
SE8802412D0 (sv) Thiourea derivatives
MX9100450A (es) Reduccion de niveles de acido urico en la sangre
NO162421C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylinderivater og syreaddisjonssalter derav.
ATE86990T1 (de) Chinolin-verbindung.
DE69110219D1 (de) 3-(1H-Indazol-3-yl)-4-pyridiname, Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
ATE63899T1 (de) 8-(niederalkyl)bicyclo(4.2.0>octanderivate mit wertvollen therapeutischen eigenschaften.
DE3777724D1 (de) 2-amino-3-aroyl-gamma-oxobenzolbuttersaeure und ihre ester.
FI922482A (fi) Foerfarande foer framstaellning av kinolinfoerening.